title: Secondary cytoreduction versus chemotherapy alone in the treatment of patients with recurrent ovarian cancer: is a randomized trial worthwhile?
authors: Paolo
authors: P
authors: Sammartino
authors: Daniele
authors: D
authors: Biacchi
authors: Marialuisa
authors: M
authors: Framarino
mesh_terms: D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000601:surgery*; D010051:Ovarian Neoplasms / Q000601:surgery*; D010053:Ovary